Clinical Trials Browser

Recruiting × OTHER × Carcinoma, Non-Small-Cell Lung × Clear all

NCT07535437 2026-04-17

A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07535463 2026-04-17

A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT02468024 2026-04-16

STABLE-MATES

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07133425 2026-04-16

A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07223424 2026-04-16

PSI-Immune

Phase 2 Recruiting

DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma Of Esophagus, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Colitis, Ulcerative, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma

NCT02596490 2026-04-15

Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03948100 2026-04-15

Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers

Phase NA Recruiting

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms

NCT06688422 2026-04-15

INSPIRE-CRT

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pneumonia

NCT07020065 2026-04-15

Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07288034 2026-04-15

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06992739 2026-04-14

PROTECT-2

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07528274 2026-04-14

Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07529145 2026-04-14

Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT06477055 2026-04-13

RAISE

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06552234 2026-04-13

REPOROS

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06660407 2026-04-13

Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07104630 2026-04-13

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07195084 2026-04-13

HyPROS-LC

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05445791 2026-04-09

METLUNG

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05852990 2026-04-09

Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06238882 2026-04-09

Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer.

Phase NA Recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03803787 2026-04-08

Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients

Phase 2 Recruiting

Radiation Fibrosis Syndrome, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms, Radiation Pneumonitis, Lung Injury

NCT04317534 2026-04-08

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT04849481 2026-04-08

The Research Plan of Taiwan Precision Medicine

Carcinoma, Non-Small-Cell Lung

NCT05713006 2026-04-08

Alectinib Pharmacokinetic in Patients With NSCLC

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06007937 2026-04-08

A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Recurrence

NCT06248606 2026-04-08

Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06079970 2026-04-07

CLEVER

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06545747 2026-04-06

Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRI

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT03586453 2026-04-03

Osimertinib In EGFR Mutant Lung Cancer

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06249282 2026-04-03

Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06500455 2026-04-03

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Phase 3 Recruiting

BreastCNSDermatologicGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT06500481 2026-04-03

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Phase 3 Recruiting

BreastCNSThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Meningeal Carcinomatosis

NCT07001618 2026-04-03

IMMUNOLIFE2

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07509333 2026-04-03

MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT07510321 2026-04-03

FL-261 Imaging for Cancer Diagnosis and Staging

GastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms

NCT07510724 2026-04-03

IKF-ReWoLuTe

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms, Small Cell Lung Carcinoma

NCT03025256 2026-04-02

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

Phase 1 Recruiting

DermatologicThoracic

Uveal Melanoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma, Meningeal Neoplasms, Nevus

NCT06114108 2026-04-02

salVage

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06745882 2026-04-02

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06840704 2026-04-02

Relief

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung, Esophagitis, Small Cell Lung Carcinoma

NCT07140315 2026-04-02

DK222 Study at Hopkins

Phase 1 Recruiting

GenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07186699 2026-04-02

Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD

Carcinoma, Non-Small-Cell Lung

NCT07348965 2026-04-02

Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT07460999 2026-04-02

Sing-a-Lung 2

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT07487883 2026-04-02

Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors

Carcinoma, Non-Small-Cell Lung, Neoplasms, Multiple Pulmonary Nodules

NCT07354061 2026-04-01

TD-ENSEMBLE

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07498933 2026-04-01

FAP-targeted PET/NIR in Lung Malignant Tumors

Carcinoma, Non-Small-Cell Lung

NCT07505173 2026-04-01

HOPE-WBRT

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT04762199 2026-03-31

MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms